Jane Street’s ProShares Ultra CRCL CRCA Stock Holding History

Jane Street’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$549K	Buy	+31,545	New	+$553K	﹤0.01%	7801
2026 Q1	–	Sell	-111,286	Closed	-$4.62M	–	13552
2025 Q4	$4.5M	Buy	+111,286	New	+$9.5M	﹤0.01%	3403

Other funds holding CRCA

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Hollencrest Capital Management Newport Beach, California $1.56B AUM 20.98% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Jane Street's CRCA Position: Q3 2026 in Review

Jane Street opened a new position in ProShares Ultra CRCL (CRCA) in Q3 2026: 31,545 shares worth $549K. The stake represents ﹤0.01% of the portfolio and ranks #7801 among its holdings. This is a return to the name: Jane Street previously reported a position in CRCA as recently as Q4 2025.

Jane Street first reported a position in CRCA in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.5M in Q4 2025. 6 funds tracked by Wall St. Rank hold CRCA as of Q3 2026.

Jane Street held 31,545 shares of ProShares Ultra CRCL worth $549K as of Q3 2026.
ProShares Ultra CRCL was a new Jane Street position in Q3 2026.
ProShares Ultra CRCL made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7801 holding.
Jane Street first reported a position in ProShares Ultra CRCL in Q4 2025 and has held it in 2 quarters since.
Jane Street's ProShares Ultra CRCL position peaked at $4.5M in Q4 2025.
6 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.